Vaccine Adjuvants Market Size And Share

  • Report Code : TIPRE00004430
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 155
Buy Now

Vaccine Adjuvants Market Size, Segments, and Trends by 2031

Buy Now

Vaccine Adjuvants Market Report Vaccine Adjuvants Market Scope and Analysis Vaccine Adjuvants Market Size and Share

Vaccine Adjuvants Market: Strategic Insights

Vaccine Adjuvants Market

  • CAGR (2022 - 2030)
    13.7%
  • Market Size 2022
    US$ 2,482.39 Million
  • Market Size 2030
    US$ 6,931.55 Million

Market Dynamics

GROWTH DRIVERS
  • Advantages of Vaccine Adjuvants to Favor Market
FUTURE TRENDS
  • Product Launches and Developments in Adjuvant Studies
OPPORTUNITIES
  • Collaborative Efforts for Vaccine Adjuvants

Key Players

  • SPI Pharma Inc
  • GSK Plc
  • CSL Ltd
  • Seppic SA
  • Hawaii Biotech Inc
  • Dynavax Technologies Corp
  • InvivoGen SAS
  • Croda International Plc
  • Novavax Inc
  • Phibro Animal Health Corp

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Adjuvant Class
  • Mineral Salt Adjuvant
  • Emulsion Adjuvant
  • Liposome Adjuvant
Type
  • Human Vaccine Adjuvant
  • Veterinary Vaccine Adjuvant